EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antibody–Drug Conjugates—Evolution and Perspectives

Adriana Aurelia Chis iD, Carmen Maximiliana Dobrea iD, Anca Maria Arseniu iD, Adina Frum iD, Luca-Liviu Rus iD, Gabriela Cormos, Cecilia Georgescu iD, Claudiu Morgovan iD, Anca Butuca iD, Felicia Gabriela Gligor iD, Andreea Loredana Vonica-Tincu iD

International Journal of Molecular Sciences · 26.06.2024 · 25 (13) · 6969

DOI: 10.3390/ijms25136969 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.06.2024. Verfasst von Adriana Aurelia Chis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania. Hauptthemen laut MEDLINE: Immunoconjugates, Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LBUS-IRG-2023, Lucian Blaga University of Sibiu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antineoplastic therapy is one of the main research themes of this century. Modern approaches have been implemented to target and heighten the effect of cytostatic drugs on tumors and diminish their general/unspecific toxicity. In this context, antibody–drug conjugates (ADCs) represent a promising and successful strategy. The aim of this review was to assess different aspects regarding ADCs. They were presented from a chemical and a pharmacological perspective and aspects like structure, conjugation and development particularities alongside effects, clinical trials, safety issues and perspectives and challenges for future use of these drugs were discussed. Representative examples include but are not limited to the following main structural components of ADCs: monoclonal antibodies (trastuzumab, brentuximab), linkers (pH-sensitive, reduction-sensitive, peptide-based, phosphate-based, and others), and payloads (doxorubicin, emtansine, ravtansine, calicheamicin). Regarding pharmacotherapy success, the high effectiveness expectation associated with ADC treatment is supported by the large number of ongoing clinical trials. Major aspects such as development strategies are first discussed, advantages and disadvantages, safety and efficacy, offering a retrospective insight on the subject. The second part of the review is prospective, focusing on various plans to overcome the previously identified difficulties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesNeoplasmsHumansAnimalsAntineoplastic AgentsAntibodies, Monoclonal

Stichwörter der Autor:innen

antibody–drug conjugatescancerclinical trialscytotoxic payloadefficacylinkermonoclonal antibodysafetytargeted therapy

Substanzen

ImmunoconjugatesAntineoplastic AgentsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Faculty of Medicine, "Lucian Blaga" University of Sibiu, 550169 Sibiu, Romania.
  • Faculty of Agriculture Science, Food Industry and Environmental Protection, "Lucian Blaga" University of Sibiu, 550012 Sibiu, Romania.

ORCID-Profile: Adriana Aurelia Chis, Carmen Maximiliana Dobrea, Anca Maria Arseniu, Adina Frum, Luca-Liviu Rus, Cecilia Georgescu, Claudiu Morgovan, Anca Butuca, Felicia Gabriela Gligor, Andreea Loredana Vonica-Tincu

Förderung

  • LBUS-IRG-2023
  • Lucian Blaga University of Sibiu

Zitieren

APA

Chis, A. A., Dobrea, C. M., Arseniu, A. M., Frum, A., Rus, L. L., Cormos, G., Georgescu, C., Morgovan, C., Butuca, A., Gligor, F. G., & Vonica-Tincu, A. L. (2024). Antibody–Drug Conjugates—Evolution and Perspectives. International Journal of Molecular Sciences, 25(13), 6969. https://doi.org/10.3390/ijms25136969

Vancouver

Chis AA, Dobrea CM, Arseniu AM, Frum A, Rus LL, Cormos G, et al. Antibody–Drug Conjugates—Evolution and Perspectives. International Journal of Molecular Sciences. 2024;25(13):6969. doi:10.3390/ijms25136969

BibTeX
@article{Chis2024,
  author = {Chis, Adriana Aurelia and Dobrea, Carmen Maximiliana and Arseniu, Anca Maria and Frum, Adina and Rus, Luca-Liviu and Cormos, Gabriela and Georgescu, Cecilia and Morgovan, Claudiu and Butuca, Anca and Gligor, Felicia Gabriela and Vonica-Tincu, Andreea Loredana},
  title = {Antibody–Drug Conjugates—Evolution and Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {6969},
  doi = {10.3390/ijms25136969}
}
Kostenlos starten →